Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa [Phase 4]
This Phase 4 clinical trial assesses immune responses after a booster vaccination with Tdap-IPV in children who previously received differen…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine [Phase 3]
Phase 3 inter-lot consistency study update for an adsorbed cell-free diphtheria-tetanus-pertussis vaccine developed by CanSino Biologics.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Establishing a Controlled Human Infection Model of Bordetella Pertussis [Phase 1]
This clinical trial update notes completion of a Phase 1 study to establish a controlled human infection model of Bordetella pertussis.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial [Phase 3]
Phase 3 clinical trial evaluating an adsorbed, three-component cell-free diphtheria-tetanus vaccine for prevention of pertussis, diphtheria,…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults [Phase 1, Phase 2]
A Phase 1/2 clinical trial entry evaluating the safety and immunogenicity of GC3111B in healthy adults, with recruitment ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series [Phase 2, Phase 3]
Phase II/III trial update evaluating the immunogenicity, safety, and lot-to-lot consistency of LBVD, a fully liquid hexavalent DTaP-HepB-IPV…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors [Phase 2]
This Phase 2 clinical trial evaluated the safety and immunogenicity of Tdap vaccination in plasma donors. The study has completed.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination [Phase 4]
A Phase 4 clinical trial from Mahidol University is evaluating long-term outcomes 10 years after a single-dose acellular pertussis vaccinati…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) [Phase 3]
Phase 3 trial evaluating a pentavalent DTP-HB-Hib vaccine for immunogenicity and safety has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Immune Response followingTdap Vaccine in Pregnancy
This clinical trial update reports on the immune response following administration of the Tdap vaccine during pregnancy. The study, sponsore…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Study of Concomitant Administration of the sIPV and DTaP or MMR [Phase 4]
Phase 4 trial evaluating concomitant administration of Sabin inactivated polio vaccine (sIPV) with DTaP or MMR vaccines; sponsored by the In…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks [NA]
This document provides an update on a Bordetella pertussis human challenge study evaluating delayed antibiotic therapy for six weeks; the tr…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) [Phase 1]
This document provides a status update on a Phase 1 clinical trial of an adsorbed cell-free five-component DPT vaccine for people aged 6 yea…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection [Phase 4]
A Phase 4 randomized study in healthy adults to evaluate how acellular pertussis vaccine affects colonisation by Bordetella pertussis using …
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial of an adsorbed cell-free five-component DPT vaccine conducted by CanSino Biologics Inc. is currently active…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) [Phase 3]
Phase 3 clinical trial update for a diphtheria, tetanus and acellular pertussis vaccine adsorbed (DTcP) developed by CanSino Biologics; the …
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Pertussis Challenge Study in Adults Vaccinated With BPZE1 [Phase 2]
Phase 2 pertussis challenge study evaluating BPZE1 in adults has completed, with results posted. The trial assessed the vaccine's effect on …
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Increasing Influenza and Tdap Vaccination of Pregnant Women [NA]
A completed clinical trial aimed at increasing influenza and Tdap vaccination among pregnant women, with results posted in January 2025.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Confirmatory Study of BK1310 in Healthy Infants [Phase 3]
A Phase 3 confirmatory trial of BK1310 in healthy infants evaluating protection against tetanus, diphtheria, pertussis, poliomyelitis, and b…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Pertussis Immunization During Pregnancy & HIV Infection
Clinical trial update on pertussis vaccination during pregnancy in women with HIV infection; the study is completed.
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 safety and immunogenicity study of a pentavalent DTwP-HepB-Hib-IPV vaccine in Indonesian infants; the t…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age [Phase 2]
Phase 2 trial to evaluate the immunogenicity of LR20062 versus control in healthy infants at 2, 4, and 6 months of age. The study targets pr…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants [NA]
This clinical trial is evaluating the safety and immunogenicity of a pentavalent DTaP-IPV/Hib vaccine in 2-month-old Chinese infants; the st…